Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 5, 2019
[A Survey of Health Food Use and Patient Satisfaction among Patients Undergoing Cancer Pharmacotherapy]Miki Kawaguchi, Michio Kimura, Eiseki Usami, et al.
Molecular and Clinical Oncology|January 19, 2019
Effect of the timing of discontinuation of last-line chemotherapy on patient prognosis in advanced and recurrent gastric cancerMichio Kimura, Shiori Kawachi, Makiko Go, et al.
Oncology|October 13, 2025
Sex Differences in Cardiotoxicity of Anaplastic Lymphoma Kinase Inhibitors: An Analysis of the FDA Adverse Event Reporting SystemHiroki Asano, Yoshihiro Noguchi, Rikuto Masuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[The frequency and risk factor of herpes zoster infection in non-Hodgkin's lymphoma patients]Eiseki Usami, Michio Kimura, Tomoko Matsuoka, et al.
Journal of Affective Disorders|October 19, 2025
Analysis of acute pancreatitis caused by multi-acting receptor-targeted antipsychotics using the Japanese claims databaseYoshihiro Noguchi, Ai Oonishi, Rikuto Masuda, et al.
Oncology|October 3, 2025
Safety and Treatment Continuity of Switching between CDK4/6 Inhibitors for Metastatic Breast Cancer due to Adverse Events: An Exploratory Single-Center Study in JapanMakiko Go, Michio Kimura, Shiori Yamada, et al.
Molecular and Clinical Oncology|July 8, 2017
Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancerMachiko Kurimoto, Michio Kimura, Eiseki Usami, et al.
International Journal of Cancer|April 15, 2024
Association between CDK4/6 inhibitors and drug-related osteonecrosis of the jaw: A pharmacoepidemiological study using the FDA Adverse Events Reporting SystemMakiko Go, Yoshihiro Noguchi, Rikuto Masuda, et al.
Oncology|December 11, 2024
Alternative Palbociclib Dosing Schedules for Hormone Receptor-Positive and HER2-Negative Metastatic Breast CancerMakiko Go, Michio Kimura, Shiori Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 11, 2019
[Examination of Actual Medical Material Cost and Cost Reduction Related to Exposure Prevention in the Preparation of Anticancer Drugs]Akihiro Moriya, Eiseki Usami, Tatsuya Hirose, et al.
Pageof 7